JFC approves Amgen settlement
The Joint Finance Committee on Wednesday unanimously approved an agreement that would allow pharmaceutical giant Amgen to complete its purchase of Horizon Therapeutics.
To access this content, you must purchase a Premium membership, or log in if you are a member.
